Chen Jing 4
4 · Biostage, Inc. · Filed Jul 1, 2022
Insider Transaction Report
Form 4
Biostage, Inc.BSTG
Chen Jing
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-29+6,241→ 6,241 totalExercise: $4.65Exp: 2032-06-29→ Common Stock, par value $0.01 per share (6,241 underlying) - Award
Stock Option (right to buy)
2022-06-29+5,016→ 5,016 totalExercise: $4.65Exp: 2032-06-29→ Common Stock, par value $0.01 per share (5.016 underlying)
Footnotes (2)
- [F1]This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on September 29, 2022, December 29, 2022, March 29, 2023 and June 29, 2023.
- [F2]This Stock Option was granted in lieu of cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, June 30, 2022, September 30, 2022 and December 31, 2022.